Celecoxib
Celecoxib is a pharmaceutical drug with 369 clinical trials. Currently 23 active trials ongoing. Historical success rate of 78.7%.
Success Metrics
Based on 229 completed trials
Phase Distribution
Phase Distribution
81
Early Stage
137
Mid Stage
115
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
74.6%
229 of 307 finished
25.4%
78 ended early
23
trials recruiting
369
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Celecoxib for ENT Pain Management
Pilot Study of IT Topotecan and Maintenance Chemotherapy for HR-EBTs in Children < 6 Years, Post Consolidation
TriGlytza®-01 Versus Metformin in Overweight and Obese Adults With Type 2 Diabetes and Inadequate Glycaemic Control Despite Metformin Therapy
The Seven Trial: Exploiting the Unfolded Protein Response
Celecoxib With Chemotherapy in Localized, Muscle-Invasive Bladder Cancer
Clinical Trials (369)
Celecoxib for ENT Pain Management
Pilot Study of IT Topotecan and Maintenance Chemotherapy for HR-EBTs in Children < 6 Years, Post Consolidation
TriGlytza®-01 Versus Metformin in Overweight and Obese Adults With Type 2 Diabetes and Inadequate Glycaemic Control Despite Metformin Therapy
The Seven Trial: Exploiting the Unfolded Protein Response
Celecoxib With Chemotherapy in Localized, Muscle-Invasive Bladder Cancer
Intensive Locoregional Chemoimmunotherapy, Intradermal Autologous Alpha-DC1 Vaccines, and Systemic Pembrolizumab for Advanced-Stage Ovarian Cancer
Phase I/II Study of Celebrex and EPO906 in Patients With Metastatic Colorectal Cancer
SARS-CoV-2 and Herpesvirus Inhibition for Ending Long COVID Dysfunction
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery
Methotrexate, Erlotinib, and Celecoxib for the Treatment of Recurrent/Metastatic Head and Neck Cancer in a Rural Midwest United States Population
Efficacy of Selective COX-2 Inhibitors in Relieving Orthodontic Pain
Brain-Based and Clinical Phenotyping of Pain Pharmacotherapy in Knee Osteoarthritis
99Tc-MDP Treatment for Knee Osteoarthritis
Stony Brook Medicine Anti-Inflammatory Trial
Arginine Supplementation to Improve Cardiovascular and Endothelial Function After NSAID Treatment
Nonopioid Analgesia After Anterior Cruciate Ligament Reconstruction
I-SPY COVID-19 TRIAL: An Adaptive Platform Trial for Critically Ill Patients
Serplulimab Combined With CAPEOX + Celecoxib as Neoadjuvant Treatment for Locally Advanced Rectal Cancer
Sirolimus in Combination With Metronomic Chemotherapy in Children With Recurrent and/or Refractory Solid and CNS Tumors
Total Knee Arthroplasty (TKA) Study of HTX-011 in an Multimodal Analgesic Regimen (MMA) Regimen
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 369